Corticosteroid
TDCS for Epilepsy
Recruiting1 award5 criteria
New York, New York
This trial is measuring the electrical fields caused by tDCS in people with implanted electrodes as part of their evaluation for epilepsy surgery, in order to improve mathematical models. The models can then be used to target tDCS to specific brain regions in healthy and sick people. The stimulations used in this trial are not expected to produce any changes in brain function.
Procedure
Noninvasive Imaging for Epilepsy
Recruiting1 award
Bethesda, Maryland
This trial will compare the sensitivities and specificities of morphometric analysis techniques using MRI images to pre- and postsurgical localization of epileptic foci in patients undergoing presurgical evaluation for medically refractory epilepsy, in order to establish an age-stratified normative imaging database.
Popular Filters
Trials for Lennox Gastaut Syndrome Patients
Device
SPEAC System for Seizure Monitoring
Recruiting1 award7 criteria
Lexington, Kentucky
This trial tests a device that monitors muscle activity to detect seizures in veterans with arm-involved motor seizures. The device alerts users when it detects unusual muscle movements, helping to identify seizures.
Soticlestat for Rare Epilepsies
Recruiting1 awardPhase 2
Phoenix, Arizona
This trial is testing a new drug to see if it is safe and effective when used with other anti-seizure drugs. Participants will take the drug twice a day and visit the clinic every few months. The study will continue as long as the participant benefits from the drug.
EMR-Based Treatment for Neurological Disorders
Recruiting3 awardsPhase 4
Evanston, Illinois
This trial will study 10 common neurological disorders at NorthShore University HealthSystem using electronic medical records (EMR). They aim to show that assigning treatments based on specific subgroups, obtaining electronic consent
Trials for Temporal Lobe Epilepsy Patients
Device
SPEAC System for Seizure Monitoring
Recruiting1 award7 criteria
Lexington, Kentucky
This trial tests a device that monitors muscle activity to detect seizures in veterans with arm-involved motor seizures. The device alerts users when it detects unusual muscle movements, helping to identify seizures.
EMR-Based Treatment for Neurological Disorders
Recruiting3 awardsPhase 4
Evanston, Illinois
This trial will study 10 common neurological disorders at NorthShore University HealthSystem using electronic medical records (EMR). They aim to show that assigning treatments based on specific subgroups, obtaining electronic consent
Phase 3 Trials
Responsive Neurostimulation for Generalized Epilepsy
Recruiting1 awardPhase 3
Nashville, Tennessee
This trial shows that the RNS System for thalamic stimulation is safe and effective for reducing primary generalized seizures in individuals 12 years of age or older with drug-resistant idiopathic generalized epilepsy.
Antiepileptic Drug
Brivaracetam for Absence Epilepsy
Recruiting1 awardPhase 3
Orlando, Florida
This trial is testing if the drug brivaracetam, used alone, is safe and effective for children and young adults aged 2 to 25 with certain types of epilepsy. The drug works by helping to control brain activity to prevent seizures.
Dietary Intervention
Ketogenic Diet vs Medication for Childhood Absence Epilepsy
Recruiting4 awardsPhase 3
Baltimore, Maryland
This trial is to assess if the modified Atkins diet is a feasible and effective option for new-onset childhood absence epilepsy, as compared to a group of children in which the parents have declined and chose to start anticonvulsant medications.
Cenobamate for Epilepsy
Recruiting2 awardsPhase 3
La Jolla, California
This trial aims to ensure the safety of cenobamate, a seizure control medication, for patients who have already participated in a previous study. Cenobamate helps by calming overactive brain signals that cause seizures. Cenobamate is a new medication approved by the FDA in 2019 for the treatment of focal-onset seizures in adults.
Trials With No Placebo
Device
SPEAC System for Seizure Monitoring
Recruiting1 award7 criteria
Lexington, Kentucky
This trial tests a device that monitors muscle activity to detect seizures in veterans with arm-involved motor seizures. The device alerts users when it detects unusual muscle movements, helping to identify seizures.
Soticlestat for Rare Epilepsies
Recruiting1 awardPhase 2
Phoenix, Arizona
This trial is testing a new drug to see if it is safe and effective when used with other anti-seizure drugs. Participants will take the drug twice a day and visit the clinic every few months. The study will continue as long as the participant benefits from the drug.
EMR-Based Treatment for Neurological Disorders
Recruiting3 awardsPhase 4
Evanston, Illinois
This trial will study 10 common neurological disorders at NorthShore University HealthSystem using electronic medical records (EMR). They aim to show that assigning treatments based on specific subgroups, obtaining electronic consent
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.